Blog


01/07/20

New Research Paper: In Vivo Analysis of the Biocompatibility and Immune Response of Jellagen 3D Scaffolds

In Vivo Analysis of the Biocompatibility and Immune Response of Jellyfish Collagen Scaffolds and its Suitability for Bone Regeneration

READ POST

25/06/20

Jellagen® announces £1.9m seed financing to develop products for therapeutic and medical device applications

The £1.9m round, which was 75% funded by international investors, will enable Jellagen to develop and partner pipeline products aimed at tissue reconstruction, diabetic wound care management and rare skin diseases.

READ POST

04/03/20

Neurons & Astrocytes on Jellagen®

Jellagen was shown to have an increased level of synchronisation when compared against Matrigel

READ POST

20/02/20

Video Interview with Mike Barbeck

Discover why collagen is such an important component for successful cell culture

READ POST

18/02/20

Jellagen® announces new Chairman of the Board, Gregg Sando.

Gregg replaces Stephane Thiroloix who will remain as a non-executive director at Jellagen®.

READ POST

06/02/20

Conference List 2020

Find the full list of conferences the Jellagen team will attend throughout 2020

READ POST

17/01/20

New Research Paper: Ovarian Cancer Lines & Jellagen®

Frontiers Journal in Bioengineering and Biotechnology titled ‘Marine Collagen Substrates for 2D and 3D Ovarian Cancer Cell Systems’

READ POST

28/11/19

Application Note: Co-culture of Astrocytes & Cortical Neurons

Co-culture of Astrocytes and Cortical Neurons

READ POST

18/10/19

The very first spheroids grown on JellaGel

Adipose-derived stem cells

READ POST

09/09/19

Jellagen® launches JellaGel™

Jellagen® launches their first purified jellyfish collagen hydrogel: JellaGel™

READ POST